Tempus AI Files IPO Amendment
Ticker: TEM · Form: S-1/A · Filed: Jun 13, 2024 · CIK: 1717115
| Field | Detail |
|---|---|
| Company | Tempus Ai, Inc. (TEM) |
| Form Type | S-1/A |
| Filed Date | Jun 13, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $35.00, $37.00, $188.0 m, $257.9 m, $320.7 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, sec-filing, amendment
TL;DR
Tempus AI just filed an S-1/A, getting closer to its IPO. Keep an eye on this one.
AI Summary
Tempus AI, Inc. filed an S-1/A amendment on June 13, 2024, for its initial public offering. The company, formerly known as Tempus Labs, Inc., is based in Chicago, Illinois, and is involved in computer programming and data processing services. This filing is an amendment to a previous registration statement, indicating ongoing preparations for its public debut.
Why It Matters
This S-1/A filing provides updated information for investors considering an investment in Tempus AI, Inc. as it moves towards becoming a publicly traded company.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it represents a company in the process of going public, which inherently carries market and execution risks.
Key Numbers
- 48 — Public Document Count (Indicates the volume of documents associated with this filing.)
Key Players & Entities
- Tempus AI, Inc. (company) — Registrant
- Tempus Labs, Inc. (company) — Former company name
- Eric Lefkofsky (person) — Chief Executive Officer, Founder and Chairman
- June 13, 2024 (date) — Filing date
- Chicago, Illinois (location) — Company headquarters
- 333-279558 (registration_number) — SEC registration number
FAQ
What is the primary purpose of this S-1/A filing?
This S-1/A filing is an amendment to the Form S-1 Registration Statement, indicating updates and revisions to Tempus AI, Inc.'s initial public offering plans.
When was this amendment filed with the SEC?
This amendment was filed on June 13, 2024.
What is Tempus AI, Inc.'s principal executive office address?
The principal executive offices are located at 600 West Chicago Avenue, Suite 510, Chicago, Illinois 60654.
Who is the Chief Executive Officer of Tempus AI, Inc.?
Eric Lefkofsky is the Chief Executive Officer, Founder and Chairman of Tempus AI, Inc.
What was Tempus AI, Inc.'s former company name?
The former company name was Tempus Labs, Inc., with a name change date of September 15, 2017.
Filing Stats: 4,543 words · 18 min read · ~15 pages · Grade level 14.4 · Accepted 2024-06-13 06:26:49
Key Financial Figures
- $35.00 — l public offering price will be between $35.00 and $37.00 per share. We have granted
- $37.00 — fering price will be between $35.00 and $37.00 per share. We have granted the underw
- $188.0 m — staff. We generated total revenue of $188.0 million, $257.9 million, $320.7 million a
- $257.9 m — erated total revenue of $188.0 million, $257.9 million, $320.7 million and $531.8 millio
- $320.7 million — enue of $188.0 million, $257.9 million, $320.7 million and $531.8 million in the years ended D
- $531.8 million — ion, $257.9 million, $320.7 million and $531.8 million in the years ended December 31, 2020, 2
- $115.6 million — 2021, 2022 and 2023, respectively, and $115.6 million and $145.8 million in the three months
- $145.8 million — 3, respectively, and $115.6 million and $145.8 million in the three months ended March 31, 202
- $89.5 m — nue generated from COVID-19 testing was $89.5 million, or 47.6% of our total revenue, $
- $94.7 m — million, or 47.6% of our total revenue, $94.7 million, or 36.7% of our total revenue, $
- $22.2 m — million, or 36.7% of our total revenue, $22.2 million, or 6.9% of our total revenue, an
- $2.7 m — lion, or 6.9% of our total revenue, and $2.7 million, or 0.5% of our total revenue for
- $2.6 m — nue generated from COVID-19 testing was $2.6 million, or 2.3% of our total revenue, an
- $0 — lion, or 2.3% of our total revenue, and $0 for the three months ended March 31, 20
- $289.8 million — rter of 2023. We incurred net losses of $289.8 million and $214.1 million in the years ended D
Filing Documents
- d221145ds1a.htm (S-1/A) — 2932KB
- d221145dex231.htm (EX-23.1) — 1KB
- g221145g00a48.jpg (GRAPHIC) — 33KB
- g221145g00b10.jpg (GRAPHIC) — 180KB
- g221145g00h05.jpg (GRAPHIC) — 225KB
- g221145g01m43.jpg (GRAPHIC) — 174KB
- g221145g02h76.jpg (GRAPHIC) — 119KB
- g221145g02n47.jpg (GRAPHIC) — 102KB
- g221145g03c00.jpg (GRAPHIC) — 28KB
- g221145g03p39.jpg (GRAPHIC) — 48KB
- g221145g04v00.jpg (GRAPHIC) — 28KB
- g221145g05a05.jpg (GRAPHIC) — 56KB
- g221145g05a06.jpg (GRAPHIC) — 79KB
- g221145g11g11.jpg (GRAPHIC) — 190KB
- g221145g11y01.jpg (GRAPHIC) — 194KB
- g221145g11y02.jpg (GRAPHIC) — 223KB
- g221145g11y05.jpg (GRAPHIC) — 246KB
- g221145g11y08.jpg (GRAPHIC) — 174KB
- g221145g11y10.jpg (GRAPHIC) — 206KB
- g221145g11y11.jpg (GRAPHIC) — 91KB
- g221145g13a34.jpg (GRAPHIC) — 207KB
- g221145g13a35.jpg (GRAPHIC) — 162KB
- g221145g13a36.jpg (GRAPHIC) — 91KB
- g221145g13a37.jpg (GRAPHIC) — 165KB
- g221145g13a38.jpg (GRAPHIC) — 167KB
- g221145g13b34.jpg (GRAPHIC) — 188KB
- g221145g13b35.jpg (GRAPHIC) — 173KB
- g221145g13b37.jpg (GRAPHIC) — 183KB
- g221145g13b38.jpg (GRAPHIC) — 200KB
- g221145g14h60.jpg (GRAPHIC) — 54KB
- g221145g14k80.jpg (GRAPHIC) — 112KB
- g221145g21l09.jpg (GRAPHIC) — 79KB
- g221145g21p04.jpg (GRAPHIC) — 146KB
- g221145g21p05.jpg (GRAPHIC) — 141KB
- g221145g21p06.jpg (GRAPHIC) — 140KB
- g221145g22t01.jpg (GRAPHIC) — 82KB
- g221145g22t02.jpg (GRAPHIC) — 76KB
- g221145g22t03.jpg (GRAPHIC) — 80KB
- g221145g33b33.jpg (GRAPHIC) — 197KB
- g221145g33y44.jpg (GRAPHIC) — 46KB
- g221145g44a44.jpg (GRAPHIC) — 145KB
- g221145g50c10.jpg (GRAPHIC) — 152KB
- g221145g54d01.jpg (GRAPHIC) — 411KB
- g221145g61t56.jpg (GRAPHIC) — 144KB
- g221145g65s60.jpg (GRAPHIC) — 174KB
- g221145g67b20.jpg (GRAPHIC) — 116KB
- g221145g67g30.jpg (GRAPHIC) — 146KB
- g221145g74v40.jpg (GRAPHIC) — 54KB
- 0001193125-24-160268.txt ( ) — 11780KB
Risk Factors
Risk Factors 28 Special Note Regarding Forward-Looking Statements 104 Market, Industry and Other Data 106
Use of Proceeds
Use of Proceeds 108 Dividend Policy 109 Capitalization 110
Managements Discussion and Analysis of Financial Condition and Results
Managements Discussion and Analysis of Financial Condition and Results of Operations 117
Business
Business 144 Management 213 Page
Executive Compensation
Executive Compensation 222 Certain Relationships and Related Party Transactions 234 Principal Stockholders 239
Description of Capital Stock
Description of Capital Stock 243 Shares Eligible for Future Sale 251 Material U.S. Federal Income Tax Consequences to Non-U.S. Holders of Our Class A Common Stock 255
Underwriting
Underwriting 259 Legal Matters 270 Experts 270 Where You Can Find Additional Information 271 Index to Consolidated Financial Statements F-1 Neither we nor any of the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. Neither we nor any of the underwriters take responsibility for, or can provide any assurance as to the reliability of, any other information that others may give you. We and the underwriters are offering to sell, and seeking offers to buy, shares of our Class A common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our Class A common stock. For investors outside the United States: neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our Class A common stock and the distribution of this prospectus outside of the United States. i Table of Contents PROSPECTUS SUMMARY This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing in our Class A common stock. You should read this entire prospectus carefully, including the sections titled Risk Factors, Managements Discussion and Analysis of Financial Condition and Results of Operations and our consolidated financial statements and the related notes included elsewhere in this prospectus, b